Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kowalewski

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Genome Medicine|May 2, 2019
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinomaMarkus W Löffler, Christopher Mohr, Leon Bichmann, et al.
Journal of Hepatology|July 12, 2016
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patientMarkus W Löffler, P Anoop Chandran, Karoline Laske, et al.
Journal of Hepatology|November 20, 2016
Erratum to "Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient"Markus W Löffler, P Anoop Chandran, Karoline Laske, et al.
Nature Communications|February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omicsJulia Velz, Lena K Freudenmann, Gioele Medici, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteerHans-Georg Rammensee, Karl-Heinz Wiesmüller, P Anoop Chandran, et al.
Nature Immunology|October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognitionAnnika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.
Science Translational Medicine|August 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapyGloria B Kim, Jens Fritsche, Sebastian Bunk, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Genome Medicine|May 2, 2019
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinomaMarkus W Löffler, Christopher Mohr, Leon Bichmann, et al.
Journal of Hepatology|July 12, 2016
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patientMarkus W Löffler, P Anoop Chandran, Karoline Laske, et al.
Journal of Hepatology|November 20, 2016
Erratum to "Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient"Markus W Löffler, P Anoop Chandran, Karoline Laske, et al.
Nature Communications|February 5, 2025
Mapping naturally presented T cell antigens in medulloblastoma based on integrative multi-omicsJulia Velz, Lena K Freudenmann, Gioele Medici, et al.
Journal for Immunotherapy of Cancer|November 16, 2019
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteerHans-Georg Rammensee, Karl-Heinz Wiesmüller, P Anoop Chandran, et al.
Nature Immunology|October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognitionAnnika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.
Science Translational Medicine|August 31, 2022
Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapyGloria B Kim, Jens Fritsche, Sebastian Bunk, et al.
Pageof 17